Commonwealth Coat of Arms of Australia

 

PB 69 of 2025

 

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Amendment Determination 2025

I, Sarah Norris as delegate of the Minister for Health and Ageing, make the following determination.

Dated  12 June 2025

Sarah Norris

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health, Disability and Ageing

 

 

 

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019

 

 

  1.     This instrument is the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Amendment Determination 2025.
  2.     This instrument may also be cited as PB 69 of 2025.

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

1 July 2025.

1 July 2025

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 84C(7) of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

1  Paragraph 6(1)(c)

Repeal the paragraph (not including the note), substitute:

(c)  either:

 (i) if the pharmaceutical benefit is a readyprepared pharmaceutical benefit—$1.48; or

 (ii) if the pharmaceutical benefit is an extemporaneouslyprepared pharmaceutical benefit—$1.91.